Various studies done on CBD oils and other cannabis products around the world have come to similar conclusions about incorrect label information [24, 53, 54] and the presence of contaminants [54-57]. In the absence of a clear legal status for CBD, or agreement on common safety and quality standards, it may not be surprising that current CBD products leave something to be desired. The time has come for regulators to give CBD the attention it deserves in order to ensure that affordable, safe, and reliable CBD products are available to those who depend on them.
This is a whole new idea to me and I can use any help you can offer. I suffer from post stroke pain in my thigh which sounds similar to the pain diabetics feel in their feet (sort of electric shocks shooting through my skin). I’ve had this 24/7 for about 5 years now. The 600 mg Gabapentin 3 times a day is no longer helping. A friend just suggested marijuana topicals which I had never heard of! Any recommendations?
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.